Blue Trust Inc. Boosts Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Blue Trust Inc. boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 88.1% in the 4th quarter, HoldingsChannel reports. The fund owned 5,398 shares of the company’s stock after buying an additional 2,528 shares during the quarter. Blue Trust Inc.’s holdings in Doximity were worth $288,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. UMB Bank n.a. grew its holdings in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares during the last quarter. Morse Asset Management Inc purchased a new position in shares of Doximity in the third quarter valued at about $46,000. GAMMA Investing LLC raised its stake in shares of Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after acquiring an additional 412 shares during the last quarter. Finally, Quarry LP boosted its holdings in shares of Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company lifted their price objective on Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a research report on Monday, January 13th. KeyCorp cut their price target on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Raymond James reaffirmed an “outperform” rating and issued a $65.00 target price (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. JPMorgan Chase & Co. boosted their price target on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Finally, Mizuho assumed coverage on shares of Doximity in a report on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 price objective for the company. Thirteen research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Trading Up 0.4 %

Shares of DOCS stock opened at $59.22 on Monday. The stock has a market capitalization of $11.06 billion, a P/E ratio of 68.06, a P/E/G ratio of 4.56 and a beta of 1.38. The firm’s 50 day moving average is $54.57 and its 200 day moving average is $44.69. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). Doximity had a net margin of 33.69% and a return on equity of 19.79%. The firm had revenue of $136.83 million during the quarter, compared to the consensus estimate of $127.05 million. During the same period in the prior year, the company posted $0.18 EPS. As a group, equities analysts predict that Doximity, Inc. will post 0.88 earnings per share for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.